Income Statement
LEONABIO, INC.
LONA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - |
|
Operating Expenses
|
34.18 | 96.78 | 127.09 | 94.02 | 64.02 | 20.00 |
|
Research & Development
|
17.50 | 70.68 | 93.79 | 61.46 | 42.79 | 13.29 |
|
Selling, General & Administrative
|
16.68 | 26.09 | 33.30 | 32.55 | 21.23 | 6.71 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-34.18 | -96.78 | -127.09 | -94.02 | -64.02 | -20.00 |
|
Non-Operating Income
|
- | - | - | - | 0.33 | -1.28 |
|
Interest Income
|
- | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | 0.00 | 0.37 |
|
Other Non-Op Income / Expense
|
1.24 | 3.96 | 7.64 | 3.22 | 0.33 | -1.28 |
|
Income Before Tax
|
- | - | - | - | - | -19.96 |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-105.61 | -96.94 | -117.67 | -95.64 | -54.85 | -19.96 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-34.18 | -96.78 | -127.09 | -94.02 | -64.02 | -20.00 |
|
Earnings Per Share (Basic)
|
-24.70 | -2.52 | -3.09 | -2.53 | - | - |
|
Diluted EPS
|
-24.70 | -2.52 | -3.09 | -2.53 | - | - |
|
Weighted Average Shares
|
4.28 | 38.48 | 38.02 | 37.73 | - | - |
|
Diluted Weighted Avg Shares
|
4.28 | 38.48 | 38.02 | 37.73 | - | - |
|
Comprehensive Income
|
-105.61 | -96.59 | -116.07 | -97.21 | -55.27 | -19.92 |